Genmab | Spese Operative

Prezzo Delle Azioni
1,853.50
Cambio Giornaliero
62.00 3.46%
Mensile
-11.23%
Annuale
17.09%
Q1 Previsione
1,806.42




Spese Operative Cambiamento Data
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Almirall EUR 517.43M 43.18M 2025-06
Amarin USD 51.37M 14.6M 2025-09
Amgen USD 5.9B 773M 2025-12
argenx SE USD 776.99M 32.87M 2025-09
AstraZeneca USD 12.53B 4.16B 2025-12
Bayer EUR 10.2B 523M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Demant DKK 9.63B 241M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Fresenius Medical Care EUR 4.43B 73.91M 2025-09
Galapagos EUR 112.83M 9.48M 2025-09
Genmab DKK 565M 38M 2025-06
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
GN Store Nord DKK 4.11B 490M 2025-12
GRIFOLS EUR 1.51B 28.3M 2025-09
Hikma Pharmaceutical USD 642M 663M 2025-06
Insmed USD 513.55M 109.86M 2025-12
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.11B 117M 2025-09
Novartis USD 9.86B 115M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
UCB EUR 2.36B 108M 2024-12


Genmab Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.